Sabra Health Care REIT, Inc. (SBRA) Stock Forecast
SBRA analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.69 / 5 from 16 analysts
- Price target
- $22.50 average of analyst targets
- Upside to target
- +16.3% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.39
- 52-week range
- $17.23 – $22.39
SBRA analyst ratings
16 analystsNumber of analysts at each rating.
SBRA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SBRA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.17 | $0.16 | $0.17 | $0.17 | −0.8% | 2 |
| Current fiscal year (2026) | $0.45 | $0.39 | $0.71 | $0.64 | −30.2% | 8 |
| Next fiscal year (2027) | $0.81 | $0.77 | $0.85 | $0.67 | +15.9% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SBRA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $236.5M | $231.2M | $246.9M | +24.4% | 5 |
| Current fiscal year (2026) | $928.0M | $910.9M | $965.1M | +19.8% | 6 |
| Next fiscal year (2027) | $1.01B | $936.3M | $1.14B | +9.3% | 7 |
SBRA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SBRA revenue: reported and forecast
SBRA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | −2.9% | 0 up · 1 down |
| Current fiscal year (2026) | $0.68 | $0.62 | $0.48 | $0.48 | $0.45 | −34.1% | 0 up · 1 down |
| Next fiscal year (2027) | $0.74 | $0.74 | $0.76 | $0.78 | $0.81 | +9.0% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SBRA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SBRA beat in 7 of 12.
What analysts expect from SBRA
16 analysts cover Sabra Health Care REIT; their consensus rating is buy (3.69 on a 1–5 scale, where 5 is a strong buy). The average price target is $22.50, 16.3% above the latest close of $19.34. Analysts expect earnings of $0.45 per share for 2026, −30.2% from a year earlier. For 2027 the average estimate is $0.81 per share on revenue of $1.0 billion. Sabra Health Care REIT beat the EPS estimate in 7 of the last 12 quarters.
Related: SBRA income statement, SBRA key metrics, SBRA chart. See the SBRA stock overview for the latest quote and news.
SBRA forecast FAQ
What is Sabra Health Care REIT's price target?
The average analyst price target for Sabra Health Care REIT is $22.50, 16.3% above the latest close of $19.34.
Is Sabra Health Care REIT a buy, hold or sell?
Of 16 analysts covering Sabra Health Care REIT, 5 rate it a strong buy, 1 a buy, 10 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Sabra Health Care REIT's EPS forecast?
Analysts forecast $0.45 per share for 2026 (range $0.39 to $0.71); for 2027 the estimate is $0.81.
What is Sabra Health Care REIT's revenue forecast?
The average revenue estimate for 2026 is $928.0 million, growth of 19.8%; for 2027 it is $1.0 billion.
When does Sabra Health Care REIT report earnings?
Sabra Health Care REIT is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $0.39.
Does Sabra Health Care REIT usually beat earnings estimates?
Sabra Health Care REIT reported EPS at or above the analyst estimate in 7 of the last 12 quarters.